Skip to main content
SpringerLink
Log in

New EudraVigilance functions: better public access to PV data

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. including the EMA, the Medicines Evaluation Board in The Netherlands, and the Pharmacovigilance Risk Assessment Committee in Belgium.

Reference

  • Postigo R, et al. EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. Drug Safety : [11 pages], 9 Mar 2018. Available from: URL: https://doi.org/10.1007/s40264-018-0647-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

New EudraVigilance functions: better public access to PV data. Reactions Weekly 1694, 10 (2018). https://doi.org/10.1007/s40278-018-43412-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-43412-y

Search

Navigation